Clinical Trial Update: Induction of HO-1; a Therapeutic Approach to Reduce Ischaemia Reperfusion Injury (IRI) Following Deceased Donor Renal Transplantation [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating induction of heme oxygenase-1 to reduce ischemia-reperfusion injury and graft failure after deceased donor renal transplantation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure
• Ischemia-reperfusion Injury

Drugs mentioned

• HO-1 induction therapy (heme oxygenase-1 inducer)

Snippet

Sponsor: University of Edinburgh | Conditions: Graft Failure, Ischemia-reperfusion Injury | Phase 3 | Status: COMPLETED